NDAORALSUSPENSION
Approved
Jan 2011
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
3
Clinical Trials (3)
Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above
Started Jun 2025
203 enrolled
Rhinitis Allergic
Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions
Started Mar 2002
60 enrolled
Healthy
Fexofenadine Hydrochloride 180 mg Tablets Under Non-Fasting Conditions
Started Jan 2002
24 enrolled
Healthy
Loss of Exclusivity
LOE Date
Aug 2, 2030
53 months away
Patent Expiry
Aug 2, 2030
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8933097 | Aug 2, 2030 | Product | — |